2013
DOI: 10.1021/cr300143v
|View full text |Cite
|
Sign up to set email alerts
|

Functionalizing Nanoparticles with Biological Molecules: Developing Chemistries that Facilitate Nanotechnology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
1,186
0
6

Year Published

2013
2013
2016
2016

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 1,230 publications
(1,195 citation statements)
references
References 2,042 publications
3
1,186
0
6
Order By: Relevance
“…Further, size and hydrodynamic diameter of the final hydrophilic QD is highly dependent on which hydrophilization strategy is used. Ligand exchange provides QDs with a small hydrodynamic diameter but typically lower PL QY, while encapsulation results in larger sizes with higher QY [29]. The final size of watersoluble QDs determines their application.…”
Section: Hydrophilization Of Qdsmentioning
confidence: 99%
See 3 more Smart Citations
“…Further, size and hydrodynamic diameter of the final hydrophilic QD is highly dependent on which hydrophilization strategy is used. Ligand exchange provides QDs with a small hydrodynamic diameter but typically lower PL QY, while encapsulation results in larger sizes with higher QY [29]. The final size of watersoluble QDs determines their application.…”
Section: Hydrophilization Of Qdsmentioning
confidence: 99%
“…Non-covalent binding is determined by hydrophobic, electrostatic, or affinity interactions between biomolecules (e.g. Ig) and the QD surface; covalent linkage is obtained via different bioconjugation chemistry using activated functional groups at the surface of QDs [29,30]. The ability to conjugate QDs to biomolecules was first performed by Bruchez [31] and Chan [32] in 1998 and has since been greatly exploited in a variety of imaging, immunoassays, and DNA sequencing techniques.…”
Section: Bioconjugationmentioning
confidence: 99%
See 2 more Smart Citations
“…At a first glance, a strong interaction is desirable to maintain stability while the system remains in the bloodstream until reaching the target cells, being internalized and escaping from the endosome if necessary. However, once in the cytosol the siRNA needs to be capable of being incorporated into the RISC complex to initiate the interference mechanism, so it should be completely or partially released from the carrier [81].…”
Section: Functionalization Of Inorganic Nanoparticles With Sirnamentioning
confidence: 99%